NovoCure Ltd — Director's Dealing 2019

Dec 26, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2019-12-20

Reporting Person: Wyss Hansjoerg (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-12-20	Ordinary Shares	G	1000000	—	Disposed	8954748	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	825649	Indirect

Footnotes

F1: Mr. Wyss possesses no voting or investment power over shares held by The Hansjoerg Wyss 2004 Descendents Trust.